RING: Male Consent Form (1158)
Citation: NIH R01AI150360. 2022. Barbara Friedland, MS., Jessica Sales, PhD. Population Council, Emory University.
Study Description: We plan to develop a multipurpose prevention technology (MPT) intravaginal ring (IVR) that releases a safe and effective combination of an estrogen, a progestin, and a non-ARV antiviral agent to prevent pregnancy and HIV infection. The unique IVR could reduce both the emergence of drug-resistant HIV and the concern of potential increased risk of HIV transmission associated with use of a progestin-only contraceptive.
Document Type(s): Consent Forms
Study Type(s): Crossover RCT
Study Method(s): Clinical Qualitative
Geography: Domestic
Study Year: 2022
Project Name: RING
Project Tags: Intravaginal - Flyer - PrEP - Recruitment - Female - Women - Advertisement - Prevention - Ring - Couples - Heterosexual
Please complete the form below to download this resource
Thank you to our contributing institutions





















